Exelixis Inc (EXEL)
34.77
+0.48
(+1.40%)
USD |
NASDAQ |
Nov 05, 16:00
35.00
+0.23
(+0.66%)
After-Hours: 19:14
Exelixis Price to Book Value: 4.364 for Nov. 5, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 4.304 |
| November 01, 2024 | 4.282 |
| October 31, 2024 | 4.167 |
| October 30, 2024 | 4.071 |
| October 29, 2024 | 3.606 |
| October 28, 2024 | 3.577 |
| October 25, 2024 | 3.498 |
| October 24, 2024 | 3.528 |
| October 23, 2024 | 3.554 |
| October 22, 2024 | 3.618 |
| October 21, 2024 | 3.597 |
| October 18, 2024 | 3.630 |
| October 17, 2024 | 3.650 |
| October 16, 2024 | 3.686 |
| October 15, 2024 | 3.579 |
| October 14, 2024 | 3.296 |
| October 11, 2024 | 3.294 |
| October 10, 2024 | 3.229 |
| October 09, 2024 | 3.194 |
| October 08, 2024 | 3.189 |
| October 07, 2024 | 3.304 |
| October 04, 2024 | 3.348 |
| October 03, 2024 | 3.296 |
| October 02, 2024 | 3.328 |
| October 01, 2024 | 3.303 |
| Date | Value |
|---|---|
| September 30, 2024 | 3.259 |
| September 27, 2024 | 3.493 |
| September 26, 2024 | 3.531 |
| September 25, 2024 | 3.507 |
| September 24, 2024 | 3.536 |
| September 23, 2024 | 3.547 |
| September 20, 2024 | 3.555 |
| September 19, 2024 | 3.610 |
| September 18, 2024 | 3.609 |
| September 17, 2024 | 3.714 |
| September 16, 2024 | 3.697 |
| September 13, 2024 | 3.561 |
| September 12, 2024 | 3.540 |
| September 11, 2024 | 3.584 |
| September 10, 2024 | 3.540 |
| September 09, 2024 | 3.433 |
| September 06, 2024 | 3.384 |
| September 05, 2024 | 3.441 |
| September 04, 2024 | 3.446 |
| September 03, 2024 | 3.476 |
| August 30, 2024 | 3.503 |
| August 29, 2024 | 3.502 |
| August 28, 2024 | 3.475 |
| August 27, 2024 | 3.462 |
| August 26, 2024 | 3.462 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.937
Minimum
Oct 10 2022
4.811
Maximum
May 11 2020
3.075
Average
3.014
Median
Price to Book Value Benchmarks
| Merck & Co Inc | 5.912 |
| Eli Lilly and Co | 53.76 |
| Novavax Inc | -- |
| BioCryst Pharmaceuticals Inc | -- |
| Biomarin Pharmaceutical Inc | 2.326 |
Price to Book Value Related Metrics
| PE Ratio | 22.29 |
| PS Ratio | 5.028 |
| PEG Ratio | 0.0495 |
| Price to Free Cash Flow | 25.85 |
| Price | 34.77 |
| Earnings Yield | 4.49% |
| Market Cap | 9.930B |
| PEGY Ratio | 0.0495 |
| Operating PE Ratio | 17.21 |
| Normalized PE Ratio | 19.56 |